Dual Stimulus-Responsive Chitosan-Based Nanoparticles Co-Delivering Doxorubicin and Quercetin for Cancer Therapy

Yifu Liu,Chang Liu,Cui Tang,Chunhua Yin
DOI: https://doi.org/10.1016/j.matlet.2021.130826
IF: 3
2021-01-01
Materials Letters
Abstract:With limited steps of chemical modification and a simple sonication-drived drug loading approach, the dually sensitive chitosan-based nanoparticles (NPs) co-delivering doxorubicin (DOX) and quercetin (QUE) (DTPQ NPs) were prepared for the treatment of liver cancer. DTPQ NPs had average particle sizes <200 nm and zeta potentials of around 28 mV. Suppressed protein adsorption at neutral conditions and in vitro release in response to glutathione (GSH) concentration were achieved. Owing to their pH and redox responsiveness and synergy of DOX and QUE, DTPQ NPs exhibited the enhanced tumor inhibition efficacy. The results demonstrated that combinational therapy based on dual stimulus-responsive NPs could offer a promising choice to cancer therapy.
What problem does this paper attempt to address?